(S)-4-(2-(2-Bromoacetamido)acetamido)-5-((3-(4-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-4-oxo-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-10-yl)benzyl)bicyclo[1.1.1]pentan-1-yl)amino)-5-oxopentanoic acid

In House Impurity
Print | Download pdf
Stock Status : <%stockStatus%>

<%deliveryStatus%>

Catalogue number: PA 08 0131054
Chemical name: (S)-4-(2-(2-Bromoacetamido)acetamido)-5-((3-(4-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-4-oxo-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-10-yl)benzyl)bicyclo[1.1.1]pentan-1-yl)amino)-5-oxopentanoic acid

CAS Number:

2734878-02-3

Category: pharmaceutical standards,intermediates,Fine Chemicals,Antibody Drug Conjugate
Synonyms:

INX-P;

Molecular form: C43H52BrN3O11
Appearance: NA
Mol. Weight: 866.8
Storage: 2-8°C Refrigerator
Shipping Conditions: Ambient
Applications: INX-P is glucocorticosteroid-target antibody drug conjugate (ADC)

(S)-4-(2-(2-Bromoacetamido)acetamido)-5-((3-(4-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-4-oxo-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-10-yl)benzyl)bicyclo[1.1.1]pentan-1-yl)amino)-5-oxopentanoic acid

2734878-02-3
| Sample COA MSDS

Enquire for (S)-4-(2-(2-Bromoacetamido)acetamido)-5-((3-(4-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-4-oxo-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-10-yl)benzyl)bicyclo[1.1.1]pentan-1-yl)amino)-5-oxopentanoic acid

Order Product

Search by Keywords – Buy 2734878-02-3 | Purchase 2734878-02-3 | Order 2734878-02-3 | Enquire 2734878-02-3 | Price of 2734878-02-3 | 2734878-02-3 Cost | 2734878-02-3 Supplier | 2734878-02-3 Distributor | 2734878-02-3 Manufacturer | 2734878-02-3 Exporter

cart bucket

×

wishlist

×
Proceed